Abstract LAP (NF-1L6 or C/EBPj#), is a liver transcriptional activator protein that confers liver-specific gene expression. Because LAP has a characteristic phosphoacceptor sequence for cAMP-dependent protein kinase A (PKA), we tested if in vitro phosphorylation of LAP by PKA modulates its interaction with specific DNA sequences. The major PKA phosphorylation site of LAP was identified as Ser15, which is a predicted PKA site. As expected, this PKA phosphorylation site disappears after mutation of Ser " to Ala. Kinetic studies with LAP and LAP Asp1" (which mimics a phosphoserine residue) demonstrated that phosphorylation ofSer " itself has no effect on DNA binding. Phosphorylation of other sites by PKA, identified in the region between Ser'" and Ser223 and at Serm', by analysis of truncated and mutated LAP peptides, resulted in an inhibition of DNA binding. LAP was also phosphorylated by purified protein kinase C in vitro, and the major phosphoacceptor was shown to be Ser2' within the DNA-binding domain of LAP.
Introduction
During the development of higher eukaryotes, certain genes become activated in a cell-type-specific manner. This tissuespecific gene activation is controlled by transcription factors that are, themselves, enriched in particular cell types such as the hepatocyte. For example, the albumin gene is specifically expressed in the liver after birth, and this expression is regulated predominantly at the level of transcription ( 1, 2) .
We have reported the isolation ofa cDNA clone encoding a
Receivedfor publication I November 1993 and in revisedform 11 February 1994. liver-activator protein, LAP, a major albumin promoter D-site binding protein that confers liver-specific gene expression (3) . LAP, a member ofthe C/EBP family (4), has also been named NF-IL6 (5), IL6-DBP (6), AGP/EBP (7), C/EBP,3 (8) , and CRP2 (9) . LAP stimulates the transcription of chimeric genes containing albumin promoter D-elements both in vivo and in vitro (3, 6) . LAP shares extensive sequence homology (71%) in its DNA-binding and leucine zipper domains with C/EBPa, and these proteins show indistinguishable DNA-binding specificity and readily heterodimerize (3, 9) . Another product ofthe LAP gene has been identified, LIP (liver-inhibitory protein), which consists of the 152 amino acids of the COOH terminus ofLAP. LIP can be translated from LAP mRNA and it behaves as an antagonist of LAP-induced transcription from the albumin promoter (10) . In response to environmental signals, modulation oftarget gene expression can be achieved through posttranslational modifications of transcriptional activators ( 1 1). For example, phosphorylation and dephosphorylation of nuclear proteins have been shown to be crucial to the ability ofthese proteins to bind to cognate DNA sequences, activate gene transcription, and/or affect progression through the cell cycle (12) (13) (14) . Likewise, activation of signal transduction pathways may result in the phosphorylation of LAP and regulation of its activity as suggested previously (3) . In this connection, it has been shown that activation of the cAMP-dependent protein kinase A (PKA)' in rat pheochromocytoma PC 12 cells causes increased phosphorylation and nuclear translocation of LAP and concomitant induction of c-fos transcription (15) . In pituitary G/C cells, calcium-regulated phosphorylation of Ser276 within the leucine zipper domain of LAP stimulates transcription from a Ca2+-calmodulin-dependent protein kinase Il-responsive element ( 13 ) . We have recently shown that phosphorylation of LAP at Ser'05 is stimulated upon activation of protein kinase C (PKC) by treatment of HepG2 cells with phorbol esters, and that this phosphorylation enhances LAP transactivation activity ( 16) .
Prompted by these reports of LAP phosphorylation in intact cells, we have studied the ability of PKA and PKC to phosphorylate LAP in vitro and have tested the effect of phosphorylation by PKA and PKC on the ability of LAP to recognize its cognate DNA elements. We show that Ser 05 is a major phosphoacceptor for PKA in vitro, but that this posttranslational modification of LAP does not affect its binding affinity phorylation site for PKC as Ser2" within the DNA-binding domain of LAP. Phosphorylation at this site markedly impaired the binding of LAP to its DNA recognition element.
Methods
Plasmid construction and site-directed mutagenesis. The full-length cDNA ofLAP subcloned in pBS (Stratagene Inc., La Jolla, CA) was cut with SphI/EcoRI and religated to obtain pBS-LAP,121. LAP<, corresponds to the major form of LAP expressed in the liver (3), because of the preferential translation from the second AUG ofLAP mRNA ( 10). Deletion of the first 21 amino acids has no effect on the function of LAP as a trans-acting factor or on its binding to DNA. In this manuscript, LAP,,21 is referred to as LAP, as reported previously (3). For site-directed mutagenesis, the cDNA of pBS LAP,,21 was used to prepare single-stranded DNA in the Escherichia coli strain JM 109 using the helper phage M l 3 KO 7, according to Sambrook et al. ( 17) . Sitedirected mutagenesis was performed by using the mutagenesis kit available from Amersham Corp. (Arlington Heights, IL) according to the supplier's instructions. The following oligonucleotides served as primers: Alal05 mutation, 5'-TA ACC GTA GTC GGC CGG CTT CTT GCT C-3'; Asp'05 mutation, 5'-TA ACC GTA GTC ATC CGG CTT CTT GCT C-3'; Ala240 mutation, 5'-CCG CTT GTC GCG AGC CTT GCG CAC CGC-3'; Asp240 mutation, 5'-CCG CTT-GTC GCG GTC CTT GCG CAC CGC-3'.
The resulting mutants were sequenced, and fragments containing the correct mutations were introduced into the LAPa1 cDNA. For expression in mammalian cells the wild type (wt) and mutant LAP cDNAs were subcloned into cytomegalovirus-driven expression vectors. These same constructs were also inserted into bacterial expression vectors, transformed into the E. coli strain BL 21 /DE-3/pLys S ( 18), and purified as described previously (3, 19 After the digestion samples were centrifuged for 10 min at 14,000g, the supernatants were transferred to fresh tubes and lyophilized. The pellet was oxidized in 50 Ml performic acid for 60 min on ice. Immediately after the incubation 400 Ml of water was added, the sample was frozen on dry ice and lyophilized. The sample was dissolved in pH 1.9 buffer and spotted on a I 00-Am cellulose TLC plate. Phosphopeptides were separated in the first dimension by electrophoresis at pH 1.9 at 1 kV for 30 min (22) . Separation in the second dimension was done by chromatography in phosphochromatography buffer (22) .
For phosphoamino acid analysis the tryptic digest was dissolved in 50 Ml 6 N HCl and incubated for 1 h at 1 10C, lyophilized, and dissolved in 5 ml of pH 1.9 buffer. The samples were mixed with 1 Mg of the unlabeled phosphoamino acids phosphoserine, phosphothreonine, and phosphotyrosine, and spotted on a lO-Am cellulose TLC plate. Samples were separated by electrophoresis for 20 min at 2 kV in the first dimension at pH 1.9 and for 20 min at 2 kV at pH 3.5 buffer (5% glacial acetic acid, 0.5% pyridine in water) in the second dimension. The unlabeled phosphoamino acids markers were visualized by ninhydrin staining, and 32P-labeled phosphoamino acids were detected by autoradiography.
Edman degradation was performed exactly as described by Boyle et al. (22) . The samples from each cycle were spotted 1 cm apart on a 100-Mm cellulose TLC plate and electrophoresed in pH 1.9 buffer for 25 min at 1 kV.
Gel retardation assays. For the gel retardation assays 1 ng ofrecombinant bacterially expressed LAP was used. An oligonucleotide (5'-TGGTATGATTTTGTAATGGGG-3') spanning the D-site of the albumin promoter ( 1 ng) was used as a probe. Free DNA and DNA-protein complexes were resolved on a 6% polyacrylamide gel as described previously (3).
Results
In vitro phosphorylation of LAP at Ser'05 by PKA. As we reported previously (3), analysis of the amino acid sequence of LAP revealed possible phosphoacceptor sites for PKA-mediated phosphorylation in the NH2 terminus of LAP. Therefore we investigated whether LAP could be a substrate ofphosphorylation by PKA in vitro. Purified bacterially expressed LAP was phosphorylated by PKA and the products were separated by SDS-PAGE. Fig. 1 A shows that phosphorylation of LAP occurred in the presence (lane 2) but not in the absence (lane 1) ofPKA catalytic subunit. Myosin light chain was used as a positive control for PKA phosphorylation (lane 3). Minor phosphorylation products (lanes 2 and 3) could be due to contaminating proteins in the PKA preparation or in the LAP preparation.
Next, we set out to identify the site(s) phosphorylated in LAP by PKA. Phosphoamino acid analysis showed that LAP was phosphorylated mainly on serine by PKA although a low level of threonine phosphorylation was also detected (Fig. 1  B) . As a next step, phosphopeptides resulting from a tryptic digest ofphosphorylated LAP were resolved by electrophoresis and chromatography in two dimensions on cellulose TLC plates. Several peptides were found to be phosphorylated ( amino acids 187-297) with PKA and performed gel shift studies. A small decrease of -30% in the DNA-binding affinity of wt LAP was observed after phosphorylation (Fig. 3 A) , initially suggesting that phosphorylation of Ser'05 inhibited DNA bind- ing. However, since phosphorylation ofthe truncated LAPsmA, which lacks Ser'05, decreased DNA binding by 65% (Fig. 3 B (Fig. 3 C) (Fig. 5 A) shows a pattern related to that found for LAP phosphorylated by PKA (compared to Fig. 2 A) . However, the intensity of three basic phosphopeptides (spots II) is much greater relative to spot I than with PKA. To obtain more information about these three spots, we performed Edman degradation on these three phosphopeptides. The three spots showed release of free phosphate either after the first or the second cycle of Edman degradation.
This analysis identified Ser223 and Ser2' as good candidate acceptor sites for phosphorylation by PKC. The relative mobilities of the three spots suggested that they might be derived by incomplete trypsin digestion of a single phosphorylation site.
Specifically, Ser21 was a likely candidate because the Arg and Lys around Ser21 occur in pairs (see Fig. 5 ), which is known to result in partial tryptic digests (22) . We noted that one ofthe predicted phosphopeptides generated by trypsin digestion ofthe sequence around Ser2" in LAP would be the same as that generated by digestion of the sequence containing the main PKC phosphorylation site in the cytoplasmic tail ofthe a subunit ofthe IL2-receptor (Fig. 5 B) . Therefore, a synthetic IL2 receptor peptide described by Woodgett et al. (24) was phosphorylated by PKC, digested with trypsin and the peptides were separated in two dimensions. The tryptic map (Fig. 5 C) showed the more basic ofthe IL2 receptor-derived phosphopeptides comigrated with the middle peptide ofthe spots II cluster (Fig. 5 A) . On the basis of this information and their relative mobilities, we tentatively identify the most acidic spot in this cluster as P.Ser240-Arg-AspLys, the central spot as P.Ser24-Arg, and the most basic spot as Lys-P.Ser240-Arg-Asp-Lys.
From these experiments we concluded that Ser21 is the main PKC phosphorylation site. Therefore, the serine codon at position 240 was mutated to an alanine codon, and recombinant-LAP Ala21 was phosphorylated by PKC in vitro. The tryptic map of LAP Ala21 showed the disappearance of the three main PKC phosphopeptide spots (Fig. 5 D) (Fig. 6 A, lane 1) , when compared with control incubations with ATP or PKC alone (Fig. 6 A, lanes 3 and 4) . The decrease in binding was partially reversed by potato acid phosphatase treatment after the phosphorylation of LAP by PKC (Fig. 6 A, lane 2) . The was probably due to the continued presence in the incubation of ATP, which acts as a competitive inhibitor of the phosphatase. Treatment with phosphatase had no effect on the phosphorylation of the oligonucleotide (Fig. 6 ).
To test whether the inhibition of DNA binding detected after phosphorylation ofLAP at Ser2" can be mimicked by the introduction of an aspartate at this position, we made and expressed an LAP Asp2" mutant. The binding of LAP Ala240 to the D-site was comparable to that of wt LAP, whereas LAP Asp21 did not bind to the D-site, (Fig. 6 B, the binding of LAP to its DNA recognition element. LIP, a liver-inhibitory protein (10) , lacks the NH2 terminal domain of LAP, including the phosphoacceptor at Ser'05, but it is susceptible to the other phosphorylations (Fig. 7) . This differential phosphorylation may provide a mechanism for selective modulation ofLAP activity, when compared with LIP activity.
Our previous study ofLAP phosphorylation in HepG2 hepatoma cells identified Ser 05 as a physiological phosphorylation site and showed that its phosphorylation was stimulated upon activation of PKC with concomitant enhancement of transcriptional activation (16 What is the potential biological relevance of LAP phosphorylation in vivo? There are potential parallels between the regulation of LAP by phosphorylation, and the regulation of other leucine zipper transcription factors by phosphorylation. c-Jun, a member of the leucine zipper family, has five major phosphorylation sites, which are located near the DNA-binding domain and in the transactivation domain within the NH2 terminus (25) (26) (27) . The affinity of c-Jun for AP-1 sites is decreased when it is phosphorylated in the region adjacent to the DNA-binding domain (25, 28) . In contrast, c-Jun shows an increase in transcriptional activity after phosphorylation oftwo serines within its transactivation domain (26, 27) . Phosphorylation also affects the activity of CREB. PKA phosphorylates CREB at Ser'"I in vitro and in vivo (29, 30) . Phosphorylation of CREB at. Ser'33, which lies in the major transactivation domain, leads to a severalfold increase in transactivation from a chimeric reporter gene with a CREB-binding site without affecting DNA binding (29) . Interestingly, this PKA-mediated phosphorylation of CREB plays a role in liver-specific gene regulation (31 ) . The tyrosine aminotransferase (TAT) gene is regulated in a hepatocyte specific manner by CREB. PKA-mediated pathways stimulate transcription of the TAT gene by CREB in a rat hepatoma cell line FTO-2B (31 ) .
Our experiments with the mutant LAP Asp 105, which exhibits increased transactivation from an LAP-responsive DNA element, support the conclusion that phosphorylation of LAP in its transactivation domain stimulates transcription of specific target genes in vivo ( 16) . This positive regulation is analogous to the stimulatory effect of phosphorylating the transactivation domain of other members of the leucine zipper family (26, 29) . Conversely, LAP displays a decreased affinity for its cognate DNA-binding sites when phosphorylated in vitro in the DNA-binding domain or in its proximity by PKC or PKA, respectively. This resembles the inhibitory effect ofphosphorylation of c-Jun in the vicinity of the basic domain, which is known to be physiologically relevant (25, 28) . LAP is also potentially positively regulated by phosphorylation of Ser276 in the leucine zipper by calmodulin-dependent protein kinase II, which would be activated upon elevation of intracellular Ca2+ (13) .
In this report we have identified and characterized the sitespecific phosphorylations of LAP critical for its interaction with cognate cis-elements in target genes. Now it will be possible to study the LAP phosphorylation site(s) in the normal rat liver as well as under physiological conditions that are known to activate various signal transduction pathways. Experiments in transgenic animals, including an LAP "knock-out" with and without overexpression ofvarious deleted/mutated LAP transgenes, should clarify the role of this site-specific phosphorylation of LAP on liver-specific gene expression during development and under physiological stimulation.
